var path='http://www.tickertech.com';
function heading(heading) {
document.write('
');
}
function hiLite(imgDocID,imgObjName) {
document.images[imgDocID].src = eval(imgObjName + ".src");
}
function showStatus(toshow) {
window.status = toshow;
}
function checkChoose() {
if (document.choose.ticker.value == "") {
alert("Please enter symbols before clicking the go button");
return false;
}
else return true;
}
function popJT(url,name){
var xwid = screen.width;
xwid = xwid - 10;
javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no');
javaticker.opener.name="opener";
//javaticker.moveTo(0,30);
}
var allow = 0;
var ref = ""+location;
if ((ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("selfdirectedinvestor.com") > 0) || (ref.indexOf("128.241.244.123") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("marketnewsvideo.mobi") > 0) || (ref.indexOf("206.71.145.70") > 0) || (ref.indexOf("206.71.145.73") > 0) || (ref.indexOf("206.71.145.76") > 0) || (ref.indexOf("selfdirectedinvestor.mobi") > 0) || (ref.indexOf("google.") > 0)) { allow = 1; }
function ShowTTIPage() {
if (allow) { document.write('\n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('5/2 - 7:30 AM \; \; | \n'); }
if (allow) { document.write('Biogen Reports Progress on Corporate Responsibility Priorities | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('4/12 - 10:36 AM \; \; | \n'); }
if (allow) { document.write('Nasdaq 100 Movers: AMD, FANG [VIDEO] | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/31 - 7:31 PM \; \; | \n'); }
if (allow) { document.write('Eisai Completes Submission of LEQEMBI®\; (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer\'s Disease to the U.S. FDA | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/21 - 10:00 AM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/19 - 11:06 AM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/18 - 11:01 AM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/17 - 11:01 AM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/15 - 11:01 AM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/14 - 7:31 PM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/14 - 7:16 PM \; \; | \n'); }
if (allow) { document.write('Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz &\; Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/11 - 3:22 PM \; \; | \n'); }
if (allow) { document.write('SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/11 - 9:00 AM \; \; | \n'); }
if (allow) { document.write('AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/9 - 12:06 PM \; \; | \n'); }
if (allow) { document.write('SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/8 - 11:28 AM \; \; | \n'); }
if (allow) { document.write('Nasdaq 100 Movers: MRVL, NVDA [VIDEO] | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('3/6 - 7:32 AM \; \; | \n'); }
if (allow) { document.write('New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write(' |
\n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write('more news | \n'); }
if (allow) { document.write('\n'); }
if (allow) { document.write(' | \n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('
\n'); }
if (allow) { document.write('